childrens allergy relief
- Product NDC
- 11822-1189
- 11-digit product format
- 118221189
- Labeler code
- 11822
- Product ID
- 11822-1189_be53cb94-0585-4db3-b195-6c14df977ddc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine HCl
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Rite Aid Corporation
- Application
- ANDA204226
- Marketing category
- ANDA
- Marketing start
- 2022-06-23
- Substance
- CETIRIZINE HYDROCHLORIDE
- Active strength
- 5 mg/5mL
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- childrens allergy relief
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CETIRIZINE HYDROCHLORIDE | 5 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 64O047KTOA |
| Rxcui | 1014673 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11822-1189-0 | childrens allergy relief | 1 in 1 CARTON | SOLUTION | 1 | | 3 |
| 11822-1189-0 | childrens allergy relief | 120 mL in 1 BOTTLE | SOLUTION | 120 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11822-1189 | CHILDRENS ALLERGY RELIEF (CETIRIZINE HCL) SOLUTION [RITE AID CORPORATION] | 3 | Current NDC, Legacy NDC, 2 package rows | 20250514_978d8779-3c00-4b21-9cc3-f6a962194dfe.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11822-1189-0 | 11822118900 | 1 BOTTLE in 1 CARTON (11822-1189-0) / 120 mL in 1 BOTTLE | 1 bottle | 2022-06-23 | 0000-00-00 | No | No | Current |